Disclaimer of Warranties
ALL MATERIALS, INFORMATION, PRODUCTS AND SERVICES INCLUDED IN OR AVAILABLE THROUGH THE SITE ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT.
Iovance has made and will continue to make diligent efforts to include accurate and up-to-date information on the Site. However, Iovance makes no warranties or representations, express or implied, that the information contained or referenced in the Site is accurate, complete, reliable or correct; that the Site will be available at any particular time or location; that any defects or errors will be corrected; or that the Site is free of viruses or other harmful components. You agree that all access to and use of the Site, any linked Site and the contents thereof are at your own risk. Because some jurisdictions do not permit the exclusion of certain warranties, these exclusions may not apply to you.
All statements and expressions on the Site are the sole opinion of Iovance and are subject to change without notice. Iovance is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision relating to securities be discussed with a financial advisor, or a broker-dealer, or a member of a financial regulatory body. The information contained on this Site has been provided as an information service only. Investors are cautioned that they may lose all or a portion of their investment in Iovance or any other company.
Limitation of Liability
Neither Iovance nor any party involved in creating, producing or delivering the Site, or any linked website, shall be liable in any manner whatsoever for any direct, incidental, consequential, indirect or punitive damages arising out of your access, use, or inability to use the Site or any linked website, or any errors or omissions in the content thereof. Iovance reserves the right to alter the content of the Site in any way (including removing links to any linked websites), at any time, for any reason, without prior notification, and will not be liable in any way for possible consequences of such changes. In addition, Iovance expressly disclaims any and all liability related to, arising from, or connected with a third-party linked website.
These limitations apply whether the alleged liability is based in contract, tort, negligence, strict liability, or any other basis, even if Iovance has been advised of the possibility of such damage. Because some jurisdictions do not allow the exclusion or limitation of incidental or consequential damages, Iovance’s liability in such jurisdictions shall be limited to the maximum extent permitted by law and any exclusion or restriction on liability for death or personal injury arising from Iovance’s negligence or fraud will not apply if it is prohibited in your jurisdiction.
Trademarks and Copyrights
The images and information contained in the Site are, to the fullest extent possible, copyrighted by Iovance and are otherwise proprietary. This Site is Copyright © 2016-2018 Iovance Biotherapeutics, Inc. The contents of Site may not be copied other than for noncommercial individual use with all copyright or other proprietary notices retained, and thereafter may not be recopied, reproduced or otherwise redistributed. Except as expressly provided above, you may not otherwise copy, display, download, distribute, modify, reproduce, republish or retransmit any information, text or documents contained in this Site or any portion thereof in any electronic medium or in hard copy, or create any derivative work based on such images, text or documents, without the express written consent of Iovance. It is the policy of Iovance to enforce its intellectual property rights to the fullest extent of the law.
IOVANCE, IOVANCE BIOTHERAPEUTICS and IOVANCE BIOTHERAPEUTICS ADVANCING IMMUNO-ONCOLOGY, and stylized and color versions of these marks, are trademarks and service marks of Iovance and its subsidiaries. Iovance’s trademarks, logos and service marks (collectively the “Trademarks”) displayed on the Site, whether or not appearing in different type or with the trademark symbol, are registered and non-registered trademarks or service marks owned by or licensed to Iovance, its affiliates, subsidiaries or related companies. Nothing on this Site should be construed as granting, by implication, estoppels or otherwise, any license or right under any patent or the Trademarks.
The use or misuse of the Trademarks or any other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, the law of slander and libel, the law of privacy and publicity, and communications regulations and statutes.
Forward Looking Statements
Certain matters discussed on the Site are “forward-looking statements.” Iovance may, in some cases, use terms such as “predicts,” “believes,” “potential,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. In particular, Iovance’s statements regarding trends and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, and include, but are not limited to, the efficacy, safety, tolerability and cost of Iovance’s manufacturing processes; the success, timing, and cost of Iovance’s ongoing clinical trials and anticipated clinical trials for its current product candidates, including statements regarding the timing of initiation and completion of the trials; statements with respect to the preliminary clinical results from ongoing clinical studies, which may not be reflected in the final analyses of these studies; whether results obtained in Iovance’s ongoing clinical trials, such as the studies and trials referred to on this Site, will be indicative of results obtained in future clinical trials; the timing of and Iovance’s ability to obtain and maintain U.S. Food and Drug Administration or other regulatory authority approval of, or other action with respect to, its product candidates; the strength of Iovance’s product pipeline; the successful implementation of Iovance’s research and development programs and collaborations; the success of Iovance’s license or development agreements; the acceptance by the market of Iovance’s product candidates, if approved; and other factors, including general economic conditions and regulatory developments, not within Iovance’s control. The factors discussed herein could cause actual results and developments to be materially different from those expressed in or implied by such statements. A further list and description of Iovance’s risks, uncertainties and other factors can be found in Iovance’s most recent Annual Report on Form 10-K and Iovance’s subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov or www.iovance.com. The forward-looking statements are made only as of the date of access to the Site, and Iovance undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance.
Last Updated February 14, 2018